Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancers.
- DOI
- 10.1016/j.omton.2024.200786
- Published
- 2024 Mar 21
- Container
- Molecular therapy. Oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.omton.2024.200786,
title = {Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancers.},
author = {Lou E and Xiu J and Baca Y and Saeed A and Prakash A and Gholami S and Subramanian S and Starr TK and Fontana E and Pandey R and Lenz HJ and Shields AF and Nabhan C and Oberley M and Seeber A and El-Deiry W},
year = {2024},
journal = {Molecular therapy. Oncology},
doi = {10.1016/j.omton.2024.200786},
url = {https://doi.org/10.1016/j.omton.2024.200786}
}RIS
TY - JOUR TI - Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancers. AU - Lou E AU - Xiu J AU - Baca Y AU - Saeed A AU - Prakash A AU - Gholami S AU - Subramanian S AU - Starr TK AU - Fontana E AU - Pandey R AU - Lenz HJ AU - Shields AF AU - Nabhan C AU - Oberley M AU - Seeber A AU - El-Deiry W PY - 2024 JO - Molecular therapy. Oncology DO - 10.1016/j.omton.2024.200786 UR - https://doi.org/10.1016/j.omton.2024.200786 ER -
APA
E, L., J, X., Y, B., A, S., A, P., S, G., S, S., TK, S., E, F., R, P., HJ, L., AF, S., C, N., M, O., A, S., & W, E. (2024). Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancers.. Molecular therapy. Oncology. https://doi.org/10.1016/j.omton.2024.200786
Source records
- pubmed · retrieved 2026-09-25T17:47:33.402Z